Glenmede Trust CO Na Karuna Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $105,348 - $133,447	-653 Reduced 27.88%	1,689 $306,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $55,926 - $69,151	292 Added 14.24%	2,342 $460,000
Q3 2022 Nov 16, 2022	SELL	$123.79 - $277.42 $80,215 - $179,768	-648 Reduced 24.02%	2,050 $461,000
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $253,531 - $386,704	2,698 New	2,698 $341,000
Q1 2021 May 18, 2021	SELL	$95.46 - $133.08 $247,241 - $344,677	-2,590 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $85,009 - $123,429	-1,130 Reduced 30.38%	2,590 $263,000
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $66,674 - $102,606	935 Added 33.57%	3,720 $287,000
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $36,973 - $69,739	595 Added 27.17%	2,785 $310,000
Q4 2019 Feb 12, 2020	BUY	$11.44 - $123.99 $25,053 - $271,538	2,190 New	2,190 $164,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.